Determination of Dosing and Frequency of BCG Administration to Alter T-Lymphocyte Profiles in Type I Diabetics
This study has been completed.
Massachusetts General Hospital
First Posted: February 5, 2008
Last Update Posted: November 5, 2013
Information provided by (Responsible Party):
David M. Nathan, MD, Massachusetts General Hospital